In July 2020, drug manufacturers started announcing that they would restrict access to 340B discounts on drugs purchased by safety net hospitals and federal grantees dispensed through community pharmacies. To date, 14 companies have formally restricted access.
This fact sheet gives an overview of the manufacturers’ different restrictions, legal milestones, and what providers can do.
© 2022 The Chartis Group, LLC. All rights reserved. This content draws on the research and experience of Chartis consultants and other sources. It is for general information purposes only and should not be used as a substitute for consultation with professional advisors.